Thorin E, Capdeville C, Trocklé G, Wiernsperger N, Atkinson J
Laboratoire de Pharmacologie, Faculté des Sciences Pharmaceutiques et Biologiques, Nancy, France.
J Cardiovasc Pharmacol. 1990;16 Suppl 3:S54-7.
Three-month-old spontaneously hypertensive rats were treated for 1, 2, or 3 months with daily intraperitoneal injections of naftidrofuryl (30 mg/kg). Systolic arterial pressure was measured. Tail arteries were removed and perfused at a constant flow rate of 2 ml/min. A concentration-response curve for serotonin was prepared. A second curve was then constructed in the presence of naftidrofuryl. Chronic treatment with naftidrofuryl had no effect on blood pressure but produced a decrease in the maximal vasoconstrictor response and the sensitivity to serotonin in vitro. The in vitro sensitivity to naftidrofuryl was unchanged. These studies suggest that chronic treatment with a dose of naftidrofuryl that does not modify blood pressure attenuates the in vitro vascular sensitivity to serotonin.
对3个月大的自发性高血压大鼠进行为期1、2或3个月的治疗,每天腹腔注射萘呋胺酯(30毫克/千克)。测量收缩动脉压。取出尾动脉,以2毫升/分钟的恒定流速进行灌注。制备血清素的浓度-反应曲线。然后在萘呋胺酯存在的情况下构建第二条曲线。萘呋胺酯的长期治疗对血压没有影响,但在体外使最大血管收缩反应和对血清素的敏感性降低。对萘呋胺酯的体外敏感性未改变。这些研究表明,用不改变血压的剂量的萘呋胺酯进行长期治疗会减弱体外血管对血清素的敏感性。